Related by context. All words. (Click for frequent words.) 79 humanized anti 72 hA# 71 CD# monoclonal antibody 70 Virulizin ® 70 YONDELIS 70 oral prodrug 70 cleavable linker 70 AEG# 70 investigational humanized monoclonal antibody 70 ENMD # 70 anti CD3 69 liposomal formulation 69 veltuzumab 69 PSMA ADC 69 CD3 monoclonal antibody 69 proteasome inhibitor 69 CR# vcMMAE 69 Azedra 69 PEGylated Fab fragment 69 ATL# [001] 69 HuMax CD4 69 anti CD# antibody 69 anticancer therapies 69 mertansine 69 relapsed multiple myeloma 68 alvespimycin 68 Aplidin 68 OHR/AVR# 68 Milatuzumab 68 Imprime PGG 68 Factor VIIa 68 enzastaurin 68 CCX# 68 MEK inhibitor 68 BAY #-# 68 cell mediated cytotoxicity 68 Dapagliflozin 68 PEG SN# 68 Aurora kinase 68 Nanobody 68 Trastuzumab 68 humanized monoclonal 68 XmAb# 68 JAK inhibitor 68 Symadex 68 Bortezomib 68 IMC A# 68 cancer immunotherapies 68 EndoTAG TM -1 68 GRN#L 68 decitabine 68 pan HDAC inhibitor 68 CYC# 68 anti CD# antibodies 68 Xanafide 67 JAK1 67 elotuzumab 67 milatuzumab 67 Fc fusion protein 67 humanized antibody 67 CDK inhibitor 67 HGS ETR1 67 tyrosine kinase inhibitor 67 PEGylated 67 Aflibercept 67 pertuzumab 67 epratuzumab 67 MAb 67 MEK inhibitors 67 antiangiogenic 67 Gleevec resistant 67 Proxinium TM 67 AQ4N 67 cetuximab Erbitux R 67 rituximab Rituxan 67 cilengitide 67 Alocrest 67 Degarelix 67 orally bioavailable 67 IMA# 67 receptor tyrosine kinase inhibitor 67 RECOTHROM R 67 Amrubicin 67 targeting CD# 67 ESBA# 67 polymerase inhibitor 67 antibody MAb 67 vidofludimus 67 immunotherapeutic agent 67 ularitide 67 dasatinib Sprycel ® 67 Sym# 67 vascular disrupting agents 67 CD# expressing 66 urocortin 2 66 Panzem R NCD 66 imatinib Gleevec ® 66 metaglidasen 66 sodium glucose cotransporter 66 Phase Ib study 66 pegylated liposomal doxorubicin 66 PDE4 inhibitor 66 paclitaxel Taxol ® 66 Civacir 66 FOLOTYN ® 66 Telatinib 66 Panzem R 66 HuLuc# 66 CCR9 antagonist 66 Insegia 66 PXD# 66 goserelin 66 entinostat 66 Traficet EN 66 EGFR inhibitors 66 Abiraterone acetate 66 TLR9 agonist 66 HSP# inhibitor 66 VitiGam 66 FGFR 66 erlotinib Tarceva ® 66 IAP inhibitor 66 CD4 monoclonal antibody 66 nalbuphine ER 66 orally administered inhibitor 66 xenograft models 66 HGS ETR2 66 Carfilzomib 66 selective agonist 66 PKC# 66 Neulasta ® 66 MyVax R 66 novel peptide 66 gefitinib Iressa 66 humanized monoclonal antibody 66 obatoclax 66 VEGF receptor 66 mapatumumab 66 Lenocta 66 TRX1 66 JAK3 66 selective modulator 66 tubulin inhibitor 66 immune modulatory 66 EGF receptor 66 EGFr 66 MGd 66 Seliciclib 66 Fludara 66 Vidofludimus 66 trastuzumab Herceptin 66 ganetespib 66 PRT# 66 forodesine 66 Velcade bortezomib 66 antibody MT# 66 drug conjugate 66 targeted antifolate 66 multiple myeloma MM 66 small molecule thrombopoietin 66 #D#C# 66 Fludara ® 66 pomalidomide 66 mu opioid receptor antagonist 66 thymalfasin 66 angiogenesis inhibitor 66 Pertuzumab 66 omega interferon 66 NXL# 66 Nexavar ® 66 HGS# 65 IFN α 65 IRX 2 65 oral proteasome inhibitor 65 PEGylated interferon 65 anticancer therapy 65 MGCD# [001] 65 CYT# potent vascular disrupting 65 VAPRISOL 65 anticancer agent 65 investigational monoclonal antibody 65 EndoTAG 65 pro angiogenic 65 antibody fragment 65 antisense oligonucleotide 65 CoFactor 65 T#I [002] 65 immunomodulator 65 sipuleucel T 65 MAGE A3 ASCI 65 HuMax CD# 65 thalidomide Thalomid 65 FVIIa 65 EGFR HER2 65 GMX# 65 otelixizumab 65 immunomodulation 65 rhIL 7 65 thrombopoietin 65 pegylated 65 CA4P 65 TELINTRA 65 IMiD 65 LEUKINE 65 lumiliximab 65 Omacetaxine 65 immunomodulating 65 INTEGRILIN 65 Squalamine 65 Marqibo TM 65 IMiDs 65 Bezielle 65 BiTE 65 CTAP# Capsules 65 Pralatrexate 65 alpha interferon 65 BCR ABL inhibitors 65 tranilast 65 rxRNA 65 Epratuzumab 65 Rituximab 65 TKM ApoB 65 Pemetrexed 65 MORAb 65 Lixivaptan 65 bispecific antibody 65 R#/MEM # 65 trastuzumab DM1 T DM1 65 HCV protease inhibitors 65 antimetabolite 65 Leukine ® 65 FLT3 65 sunitinib malate 65 Cleviprex TM clevidipine 65 PHX# 65 EOquin 65 G CSF 65 OXi# 65 ARIKACE ™ 65 ELACYT 65 Lenalidomide 65 JAK inhibitors 65 monoclonal antibody mAb 65 inhibitor RG# 65 docetaxel Taxotere ® 65 protein kinase inhibitor 65 Cloretazine ® 65 Decitabine 65 PI3K inhibitor 65 Mipomersen 65 Targretin 65 OncoVEX 65 antiangiogenic therapy 65 synthetic retinoid 64 PRTX 64 sunitinib Sutent ® 64 glucagon receptor 64 CHOP chemotherapy 64 isoform selective 64 CIMZIA ™ 64 Tesetaxel 64 tanespimycin 64 epothilones 64 Golimumab 64 tafamidis 64 adecatumumab 64 vinorelbine 64 selective inhibition 64 protein tyrosine phosphatase 1B 64 CORT # 64 Tumour Vascular Disrupting Agent 64 interleukin IL -# 64 favorable pharmacokinetic profile 64 telaprevir VX 64 peptibody 64 ixabepilone 64 immune modulating 64 Fulvestrant 64 HCV protease inhibitor 64 Vandetanib 64 galiximab 64 HQK 64 cetuximab Erbitux ® 64 GW# [003] 64 phase IIb clinical 64 Liposomal 64 IgG1 monoclonal antibody 64 tiapamil 64 HuMax EGFr 64 Pradefovir 64 LHRH antagonists 64 Vascular Endothelial Growth 64 chimeric monoclonal antibody 64 INCB# [001] 64 Navelbine 64 OncoVEX GM CSF 64 bevacizumab Avastin ® 64 Tyrima 64 ALN PCS 64 Ceflatonin R 64 Copegus ribavirin 64 Navelbine ® 64 INCB# [002] 64 vWF 64 volociximab 64 Quinamed 64 selective adenosine 64 luteinizing hormone releasing 64 eniluracil 64 ALN TTR 64 busulfan 64 epigenetic therapies 64 trabectedin 64 mRCC 64 JAK2 inhibitor 64 oxaliplatin Eloxatin 64 immunotoxin 64 EOquin TM 64 Sapacitabine 64 INT# [002] 64 Anticalins R 64 Neupogen ® 64 Cimzia ® certolizumab pegol 64 belinostat 64 Pathway Inhibitor 64 Vaprisol 64 ® bortezomib 64 Luteinizing Hormone Releasing Hormone 64 TACI Ig 64 TBC# 64 partial agonist 64 Voreloxin 64 GHRH 64 Genentech Rituxan 64 panobinostat 64 panitumumab Vectibix 64 SAR# [004] 64 Personalized Immunotherapy 64 multi kinase inhibitor 64 hypoxia inducible factor 64 Panzem 64 factor Xa 64 IV Busulfex 64 phase IIb trial 64 selective antagonist 64 bispecific 64 AAG geldanamycin analog 64 IAP inhibitors 64 azacitidine 64 ZOLINZA 64 idarubicin 64 DAVANAT 64 delafloxacin 64 CBLC# 64 adenoviral 64 custirsen 64 SPRYCEL ® 64 small molecule tyrosine 64 HER2 positive metastatic breast 64 sargramostim 64 Ecallantide 64 INGN 64 selective androgen receptor modulator 64 PI3K/Akt pathway inhibitor 64 Marqibo 64 methylnaltrexone 64 Anticalin R 64 AP# [003] 64 trastuzumab DM1 64 Zybrestat 64 Dasatinib 64 synthetic peptide 64 antisense oligonucleotides 64 CIMZIA TM 64 Dacogen decitabine 64 telomerase therapeutic 64 potent antiproliferative 64 5 Fluorouracil 64 histone deacetylase HDAC inhibitor 64 ANYARA 64 Enkephalin 64 alpha folate receptor 64 Laquinimod 64 imetelstat 64 Relivar 64 zanolimumab 64 Onalta 64 microtubule inhibitor 64 menadione 64 davunetide intranasal AL 64 antidiabetic 64 ara C 64 peptidic compound 64 OMP #M# 64 interferon beta 1a 64 immune modulator 64 anticancer agents 64 mecamylamine 64 ZEVALIN ® 64 Homspera TM 64 liposomal doxorubicin 64 alefacept 64 teriflunomide 64 immunostimulatory 64 Guanilib 64 effector function 64 PI3K Akt 64 Interferon alpha 64 Onco TCS 64 seliciclib 64 Cloretazine 64 Clolar ® 64 HDACi 64 biologic therapy 64 Interferon alfa 64 Apoptone 64 NTDDS 64 neratinib 64 EGFR HER 64 Azacitidine 64 cannabinor 64 Capesaris 64 Chemophase 64 TAFA# 64 CTLA 4 64 Allovectin 7 R 64 Gleevec Glivec 64 Vicinium TM 63 orally bioavailable mimics 63 antithrombotic 63 Azilect ® 63 Cloretazine VNP#M 63 refractory AML 63 vinca alkaloid 63 imatinib Gleevec 63 Oral NKTR 63 regorafenib 63 A3 adenosine receptor 63 colon carcinoma 63 Aptivus ® 63 ALN TTR# 63 Nanobody ® 63 ISF# 63 trastuzumab Herceptin R 63 triphendiol 63 chemotherapy induced neutropenia 63 #ME# 63 rFVIII 63 dasatinib Sprycel 63 IMC #B 63 DiLA2 63 Talabostat 63 ErbB3 63 anti leukemic 63 histone deacetylase inhibitor 63 mTOR inhibitor 63 anti EGFR antibody 63 chemotherapeutics 63 BAL# [001] 63 ISIS # 63 castration resistant prostate cancer 63 EpCAM 63 inhibiting tumor 63 huC# DM4 63 HCD# [002] 63 TREANDA 63 LNP formulations 63 polymerase inhibitors 63 IL# PE#QQR 63 Irinotecan 63 OvaRex R 63 receptor inhibitor 63 novel topoisomerase 63 lipid nanoparticle 63 anti angiogenic agents 63 sorafenib tablets 63 PROCHYMAL 63 SERMs 63 systemic RNAi therapeutic 63 PSN# [002] 63 TGR5 63 selective immunoproteasome inhibitor 63 vascular disrupting agent 63 nucleoside analog 63 tumor xenograft models 63 TRV# [001] 63 DXL# 63 subcutaneously administered 63 elacytarabine 63 BRAF inhibitor 63 LymphoStat B belimumab 63 kinase inhibitor 63 Bicifadine 63 Ocrelizumab 63 Zorbtive TM 63 viral kinetics 63 Ozarelix 63 compound AEZS 63 Octreotide 63 IGF 1R 63 Phase Ib clinical trials 63 immunotherapeutic 63 M1 muscarinic 63 leading oral taxane 63 Rebif ® 63 erlotinib Tarceva 63 KSP inhibitor 63 bevacizumab Avastin R 63 octreotide acetate 63 epothilone 63 Annamycin 63 AKT inhibitor 63 ATL/TV# 63 ACZ# 63 Gemcitabine 63 daptomycin 63 Increlex R 63 gemcitabine Gemzar 63 LHRH antagonist 63 interferon IFN 63 Kahalalide F 63 AEZS 63 intravesical instillation 63 corticosteroid dexamethasone 63 JVRS 63 Tarvacin 63 MNTX 63 Lubiprostone 63 MYDICAR ® 63 atacicept 63 Litx 63 peripherally acting 63 ruxolitinib 63 myelofibrosis polycythemia vera 63 evaluating tivozanib 63 HER2 antibody 63 Blinatumomab 63 Myocet 63 relapsed refractory multiple myeloma 63 Ceflatonin 63 nucleotide analog 63 Aliskiren 63 bortezomib Velcade 63 Enzastaurin 63 PDX pralatrexate 63 Herceptin trastuzumab 63 Galectin 63 SCCHN 63 radiation sensitizer 63 targeted radiotherapeutic 63 rNAPc2 63 antitumor activity 63 Triapine R 63 alkylating agent 63 cytostatic 63 DermaVir 63 Pazopanib 63 dextromethorphan quinidine 63 Thrombin 63 Tamibarotene 63 EndoTAG TM 63 RGB # 63 Solazed TM 63 MAXY G# 63 Angiocept 63 mAb 63 Erlotinib 63 chemotherapeutic drug 63 factor G CSF 63 GAP #B# 63 proteasome inhibitors 63 AEGR 63 Archexin 63 fosbretabulin 63 rHuPH# 63 Interferon beta 63 ulimorelin 63 chemically modified siRNA 63 Taxotere ® 63 Taxotere docetaxel 63 beta 1a 63 Azedra TM 63 RECOTHROM ® 63 oral JAK1 63 recombinant factor VIIa 63 Icatibant 63 potent anti angiogenic 63 GRNVAC1 63 cathepsin K inhibitor 63 anticancer compound 63 Elvitegravir 63 thrombopoietin TPO 63 proprietary polysaccharide 63 investigational pan BCR 63 mitomycin 63 gastrointestinal stromal tumors GIST 63 Granulocyte Colony Stimulating Factor 63 pegfilgrastim 63 L asparaginase 63 therapeutic monoclonal antibody 63 zileuton 63 huN# DM1 63 Safinamide 63 Nanobodies ® 63 CCX# B 63 INCB# [003] 63 refractory chronic lymphocytic 63 Methylnaltrexone 63 Evoltra ® 63 deacetylase inhibitors 63 Intravenous Human 63 Aurora Kinase 63 acetylcholinesterase AChE 63 fulvestrant 63 IMiDs R 63 ON #.Na 63 Vitaxin 63 calcineurin inhibitor 63 Gefitinib 63 cediranib 63 Menadione 63 AVE# 63 IFN alpha 63 xanthine oxidase inhibitor 63 gastrin 63 Genasense ® 63 DOS# 63 APOPTONE 63 LHRH 63 BZL# 63 Vorinostat 63 PNP inhibitor 63 interferon alfa 62 ADP receptor antagonist 62 antitumoral 62 Loramyc R 62 monoclonal 62 glufosfamide 62 indibulin 62 EGFR receptor 62 docetaxel Taxotere R 62 docetaxel Taxotere 62 soluble tumor necrosis 62 VEGF receptors 62 Aloxi injection 62 c MET 62 anti angiogenic agent 62 Dacogen injection 62 visilizumab 62 ProSavin 62 AVONEX ® 62 antisense inhibitors 62 Pharmacokinetics PK 62 immunoconjugate 62 ceftazidime 62 radezolid 62 CINTREDEKIN BESUDOTOX 62 potency selectivity 62 ARIKACE 62 Debio 62 ISTODAX 62 Aplidin R 62 PI3K/mTOR 62 mGluR2 NAM 62 Virulizin R 62 vinorelbine tartrate 62 T DM1 62 G#DT 62 Apaziquone 62 velafermin 62 5HT 62 TNFa 62 deforolimus 62 P#X# antagonist 62 IgG1 antibody 62 imatinib resistant 62 nicotinic acetylcholine receptor 62 R sorafenib tablets 62 therapeutic monoclonal antibodies 62 sitaxsentan 62 standard chemotherapy regimen 62 delta isoform 62 immunotoxins 62 LY# [003] 62 hematological tumors 62 TMC# [002] 62 CEQ# 62 LY# [002] 62 CTLA4 Ig 62 Leukine 62 AMD# [003] 62 monoclonal antibody therapeutics 62 valopicitabine 62 mAbs 62 ganaxolone 62 octreotide implant 62 BrachySil TM 62 TNFα 62 novel antibody therapeutics 62 Onconase 62 adalimumab Humira 62 bortezomib Velcade R 62 TG# [003] 62 immatics 62 AzaSite Xtra 62 Trofex 62 Recombinant Human 62 Novolimus 62 ospemifene 62 molecularly targeted 62 intranasal formulation 62 nicotinic alpha 7 62 rilonacept 62 IMGN# 62 colony stimulating factor 62 selectively inhibited 62 investigational compounds 62 malignant ascites 62 NS4A 62 amikacin 62 adipiplon 62 Taxol ® 62 Linaclotide 62 monoclonal antibody 62 IFN beta 62 Temsirolimus 62 Phase #b/#a clinical 62 intravesical infusion therapy 62 paclitaxel Taxol 62 virus HCV protease inhibitor 62 somatostatin analogue 62 FavId 62 anti CD# monoclonal 62 Micromet BiTE 62 DXL TM 62 metastatic sarcoma 62 TLR9 agonists 62 nitric oxide donating 62 Neulasta R 62 Nexavar sorafenib 62 MDV# 62 gemcitabine cisplatin 62 K RAS 62 antisense inhibition 62 ThGRF 62 Trastuzumab DM1 62 Chemokine Receptor 62 CytoFabTM 62 biologic therapeutics 62 RAV# 62 ZFP TF 62 FOLFOX6 62 cMET 62 Factor Receptor 62 MAbs 62 ZK EPO 62 etanercept Enbrel 62 amrubicin 62 M2 subunit 62 AeroLEF TM 62 COLAZAL R 62 ketolide antibiotic 62 C5a 62 pegylated interferons 62 lintuzumab 62 interferon alpha 62 Hycamtin 62 MOZOBIL 62 oral nucleoside analogue 62 signal transduction inhibitor 62 liposomal 62 humanized monoclonal antibodies 62 oblimersen 62 CD# antibodies 62 ponatinib 62 paclitaxel Taxol R 62 calcitriol 62 cytotoxic agents 62 PEGylated anti 62 Pegylated Interferon 62 #HT#A 62 NeuVax 62 muscarinic 62 poly ADP ribose polymerase 62 docetaxel chemotherapy 62 Bendamustine 62 REP# 62 Panitumumab 62 TNF α 62 PS# [001] 62 Ixempra 62 polyclonal antibody 62 Fleximer 62 oncology therapeutics 62 Pimavanserin 62 depsipeptide 62 diarrhea predominant irritable 62 Increlex ® 62 cytoprotective 62 nucleoside 62 antisense drug 62 stable nucleic acid 62 flavopiridol 62 TLR agonists 62 preclinically 62 Campath ® 62 Perifosine 62 BiTE antibody 62 TRISENOX ® 62 lenalidomide dexamethasone 62 IMP# 62 vorinostat 62 INTERCEPT platelets 62 peptidomimetic 62 miR #a [002] 62 apoptotic pathway 62 piperacillin tazobactam 62 Allovectin 7 62 DermaVir Patch 62 metastatic renal cell carcinoma 62 IFN β 62 AtuRNAi 62 HCV replicon 62 XL# XL# 62 5alpha reductase 62 Olmesartan 62 Anticalin ® 62 Saizen R 62 Elotuzumab 62 insulin sensitizer 62 PSN# [001] 62 Natalizumab 62 maribavir 62 reslizumab 62 OMP #R# 62 pitavastatin 62 P#X# 62 Xencor XmAb 62 familial amyloidotic polyneuropathy FAP 62 Axiogenesis 62 Fibroblast Growth Factor Receptor 62 auristatin 62 immunomodulatory therapy 62 Treanda 62 Filgrastim 62 Melphalan 62 Etoposide 62 Gemzar ® 62 effector functions 62 ORENCIA R 62 ALN VSP 62 Triapine 62 Allovectin 7 ® 62 budesonide foam 62 Toraymyxin TM 62 Alkeran 62 Vidaza R 62 novel histone deacetylase 62 TRC# 62 Symphogen 62 plasma kallikrein inhibitor 62 pathophysiological effects 62 Factor VEGF 62 RAPAFLO 62 Xeloda ® 62 GVAX 62 ONCASPAR 62 Targretin capsules 62 Calcitonin 62 XYOTAX TM 62 Nilotinib 62 brostallicin 62 5 HT3 receptor 62 MKC# MT 62 posaconazole 62 bortezomib 62 Spiegelmers R 62 Anavex #-# 62 trastuzumab emtansine T DM1 62 Removab 62 5 HT6 receptor 62 C5aR 62 CHO cells 62 Curaxin CBLC# 62 vascular disrupting 62 IMiDs ® compound 62 TGF beta1 62 cytotoxicity assays 62 oritavancin 62 azacytidine 62 mTOR inhibitors 62 BCR ABL 62 gemcitabine carboplatin 62 histone deacetylase HDAC 62 Campath alemtuzumab 62 Sphingomab TM 62 carcinoid syndrome 62 vitro assay 62 cell lymphoma CTCL 62 Optiquel ™ 62 MTP inhibitor 62 BAL# [002] 62 MKC# MKC# PP 62 XmAb 62 herpetic keratitis 62 Actimmune ® 62 investigational antiplatelet agent 62 Oritavancin 62 Atiprimod 62 survivin 62 Curaxin 62 peripheral blood mononuclear 61 including eniluracil ADH 61 Factor IX 61 camptothecin 61 IL #E 61 recombinant antibodies 61 Sudhir Agrawal D.Phil 61 Shigamabs ® 61 PEG IFN 61 ALK inhibitor 61 EGS# 61 oral picoplatin 61 kinase inhibition 61 Meets Primary Endpoint 61 SAR# [002] 61 TLE3 61 Factor Xa inhibitor 61 DepoVax TM 61 p# inhibitor 61 Zolinza 61 platinum chemotherapeutic 61 nilotinib Tasigna ® 61 SinuNase 61 anti amnesic 61 RNAi therapeutic targeting PCSK9 61 microtubule targeting 61 castrate resistant prostate cancer 61 VEGF inhibitors 61 Adnectin 61 cariprazine 61 preclinical efficacy 61 clodronate 61 eltrombopag 61 RhuDex ® 61 immune modulators 61 carfilzomib 61 EFAPROXYN 61 TriRima 61 cancer vaccine Norelin 61 sapacitabine CYC# 61 Synavive 61 DUROS 61 DAVANAT R 61 Chemokine 61 biologic therapies 61 CCR2 61 p# inhibitors 61 Flt3 61 superficial bladder cancer 61 sorafenib Nexavar 61 immunomodulatory 61 anti proliferative 61 Gleevec imatinib mesylate 61 ofatumumab 61 topoisomerase II inhibitor 61 lomitapide 61 recombinant plasma 61 Phase 2a trial 61 HIF 1a 61 YONDELIS R 61 relapsed MM 61 Neuradiab 61 angiogenesis inhibition 61 ONTAK 61 Dalbavancin 61 LEP ETU 61 Maribavir 61 modulator SERM 61 nonclinical studies 61 5 HT2C receptor 61 selective inhibitor 61 estramustine 61 radionuclide therapy 61 oral ridaforolimus 61 Daclizumab 61 ganciclovir 61 agonistic human 61 metastatic CRC 61 RIGScan CR 61 antitumor effect 61 Radiation Therapy SIRT 61 NS#/#A protease 61 insulin analogs 61 RLY# 61 generation antisense inhibitor 61 cytolytic 61 Protein Kinase C 61 antitumor effects